Alfred G. Gilman

Alfred G. Gilman, born on July first, nineteen forty-one, was a distinguished American pharmacologist and biochemist renowned for his groundbreaking work in cell signaling. He shared the prestigious Nobel Prize in Physiology or Medicine in nineteen ninety-four with Martin Rodbell, recognized for their pivotal discovery of G-proteins and their essential role in signal transduction within cells.

The son of Alfred Gilman, co-author of the influential text Goodman & Gilman's The Pharmacological Basis of Therapeutics, he pursued his education at Yale University, earning a Bachelor of Arts in biology with a major in biochemistry. Following his graduation in nineteen sixty-two, he began his career at Burroughs Wellcome & Company under the mentorship of Allan Conney, leading to the publication of his initial technical papers. Encouraged by Earl Wilbur Sutherland, Jr., he enrolled in an MD–PhD program at Case Western Reserve University School of Medicine, where he completed his degree in nineteen sixty-nine.

After his studies, Gilman worked at the National Institutes of Health alongside Marshall Nirenberg from nineteen sixty-nine to nineteen seventy-one. He then joined the University of Virginia School of Medicine as an assistant professor of pharmacology in nineteen seventy-one, advancing to full professor by nineteen seventy-seven. In nineteen eighty-one, he took on the role of chair of the Department of Pharmacology at the University of Texas Southwestern Medical Center at Dallas, a position he held until his retirement in two thousand nine. Following his retirement, he served as the chief scientific officer of the Cancer Prevention and Research Institute of Texas until two thousand twelve.

Gilman's contributions to science extended beyond academia; he was a founder of Regeneron Pharmaceuticals and the Alliance for Cellular Signaling, and he served as a director at Eli Lilly and Company starting in two thousand five. His research elucidated the mechanisms of G proteins, which act as crucial intermediaries in cellular communication, a discovery that has had lasting implications in the field of pharmacology.

Throughout his illustrious career, Gilman received numerous accolades, including the Canada Gairdner Foundation International Award in nineteen eighty-four, the Albert Lasker Award for Basic Medical Research, and the Louisa Gross Horwitz Prize in nineteen eighty-nine. He was also elected to the National Academy of Sciences and the American Academy of Arts and Sciences, and became a Fellow of the American Association for Cancer Research Academy, further solidifying his legacy in the scientific community.